N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide

C59H64N4O9 — CID 158474204

IUPACN-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide
SMILESCOc1cc2c(cc1OCc1cc(COc3cc4c(cc3C)C(=O)N3c5ccccc5C[C@H]3CC4)cc(NC(=O)CCC(=O)CNC(=O)CCC(=O)CCC(C)(C)C)c1)CC[C@@H]1Cc3ccccc3N1C2=O
InChIInChI=1S/C59H64N4O9/c1-36-24-48-39(14-16-44-28-41-10-6-8-12-50(41)62(44)57(48)68)30-52(36)71-34-37-25-38(27-43(26-37)61-56(67)21-19-47(65)33-60-55(66)20-18-46(64)22-23-59(2,3)4)35-72-54-31-40-15-17-45-29-42-11-7-9-13-51(42)63(45)58(69)49(40)32-53(54)70-5/h6-13,24-27,30-32,44-45H,14-23,28-29,33-35H2,1-5H3,(H,60,66)(H,61,67)/t44-,45-/m1/s1
InChIKeyPHVPHPLAMDCHHK-GSFSDPDBSA-N
MW973.18 g/mol
LogP9.78
Rot. Bonds18

About N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide

N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide (PubChem CID 158474204) has the molecular formula C59H64N4O9 and a molecular weight of 973.18 g/mol. Its IUPAC name is N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide.

Molecular Properties

Compound NameN-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide
PubChem CID158474204
Molecular FormulaC59H64N4O9
Molecular Weight973.18 g/mol
Exact Mass972.47
IUPAC NameN-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide
SMILESCOc1cc2c(cc1OCc1cc(COc3cc4c(cc3C)C(=O)N3c5ccccc5C[C@H]3CC4)cc(NC(=O)CCC(=O)CNC(=O)CCC(=O)CCC(C)(C)C)c1)CC[C@@H]1Cc3ccccc3N1C2=O
InChIInChI=1S/C59H64N4O9/c1-36-24-48-39(14-16-44-28-41-10-6-8-12-50(41)62(44)57(48)68)30-52(36)71-34-37-25-38(27-43(26-37)61-56(67)21-19-47(65)33-60-55(66)20-18-46(64)22-23-59(2,3)4)35-72-54-31-40-15-17-45-29-42-11-7-9-13-51(42)63(45)58(69)49(40)32-53(54)70-5/h6-13,24-27,30-32,44-45H,14-23,28-29,33-35H2,1-5H3,(H,60,66)(H,61,67)/t44-,45-/m1/s1
InChIKeyPHVPHPLAMDCHHK-GSFSDPDBSA-N
XLogP9.78
TPSA160.65 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds18
Heavy Atoms72
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500973.18
LogP ≤ 59.78
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide?
The IUPAC name of N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide (CID 158474204) is N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide.
What is the SMILES notation for N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide?
The canonical SMILES for N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide is COc1cc2c(cc1OCc1cc(COc3cc4c(cc3C)C(=O)N3c5ccccc5C[C@H]3CC4)cc(NC(=O)CCC(=O)CNC(=O)CCC(=O)CCC(C)(C)C)c1)CC[C@@H]1Cc3ccccc3N1C2=O.
What is the InChIKey of N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide?
The InChIKey is PHVPHPLAMDCHHK-GSFSDPDBSA-N. The full InChI is InChI=1S/C59H64N4O9/c1-36-24-48-39(14-16-44-28-41-10-6-8-12-50(41)62(44)57(48)68)30-52(36)71-34-37-25-38(27-43(26-37)61-56(67)21-19-47(65)33-60-55(66)20-18-46(64)22-23-59(2,3)4)35-72-54-31-40-15-17-45-29-42-11-7-9-13-51(42)63(45)58(69)49(40)32-53(54)70-5/h6-13,24-27,30-32,44-45H,14-23,28-29,33-35H2,1-5H3,(H,60,66)(H,61,67)/t44-,45-/m1/s1.
What are the key properties of N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide?
N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide has a molecular weight of 973.18 g/mol, XLogP of 9.78, 18 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[3-[[(12aR)-8-methoxy-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]-5-[[(12aR)-8-methyl-6-oxo-11,12,12a,13-tetrahydroindolo[1,2-b][2]benzazepin-9-yl]oxymethyl]anilino]-2,5-dioxopentyl]-7,7-dimethyl-4-oxooctanamide is sourced from PubChem (CID 158474204), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).